| | | | | |
ANIK Anika Therapeutics Inc | €18,3655 | -0,74% | €252,90M | €39,14K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €9,0026 | +0,14% | €252,82M | €1,21K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,5909 | -0,25% | €252,78M | €349,12 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €36,2935 | -1,97% | €252,65M | €9,99K | |
| €37,4644 | -3,28% | €252,50M | €8,27K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,5917 | +0,16% | €252,49M | €5,99K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6458 | -0,01% | €252,48M | €272,78 | |
SLN Silence Therapeutics Plc American Depository Share | €11,7390 | -2,94% | €252,42M | €460,78K | |
MTNE CH4 Natural Solutions Corporation | €8,4802 | +0,15% | €252,09M | €2,91K | |
RXST RxSight, Inc. Common Stock | €5,2892 | -3,20% | €251,89M | €243,10K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,1227 | -0,14% | €251,78M | €50,60K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,5943 | +0,14% | €251,75M | €238,92K | |
CNXU Conexeu Sciences Inc. Common Stock | €7,2570 | -15,30% | €251,56M | €260,45K | |
| €8,8268 | +3,00% | €251,31M | €659,59K | |
JCE Nuveen Core Equity Alpha Fund | €14,7636 | +0,77% | €251,15M | €21,29K | |
